How Rachman was paid
$1.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Total |
|---|---|---|---|---|
| Ilya RachmanChief Executive Officer | $475,000 | $592,854 | $285,000 | $1,352,854 |
| Gabriel MorrisChief Financial Officer | $475,000 | $592,854 | $285,000 | $1,352,854 |
What changed and why
- $1.4MIlya Rachman received a total compensation of $1,352,854 for fiscal year 2025, representing an increase from the prior year total of $1,267,158.
- $475KBase salaries for executive officers remained flat at $475,000 for both the CEO and CFO in 2025.
- $593KOption awards granted to the CEO increased in value to $592,854 in 2025 from $554,658 in 2024.
- $285KNon-equity incentive plan compensation rose to $285,000 for 2025 following full achievement of corporate and operational milestones.
- Milestones included clinical trial dosing, drug supply manufacturing, prominent publications, team expansion, and capital raising activities.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.